Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-05-24 Sale | 2022-05-26 6:19 pm | GENOCEA BIOSCIENCES INC. | GNCA | Behbahani Ali Director 10% Owner | 10,376,936 | $0.07234 | $750,662 | 0 (Indirect) | View |
| 2022-04-11 Purchase | 2022-04-13 5:10 pm | Trevi Therapeutics Inc. | TRVI | Behbahani Ali 10% Owner | 3,580,526 | $1.9 | $6,802,999 | 3,948,948 (Indirect) | View |
| 2021-12-10 Sale | 2021-12-27 4:41 pm | Metacrine Inc. | MTCR | Behbahani Ali 10% Owner | 497,270 | $0.9944 | $494,483 | 2,563,257 (Indirect) | View |
| 2021-10-18 Purchase | 2021-10-19 9:11 pm | Trevi Therapeutics Inc. | TRVI | Behbahani Ali 10% Owner | 1,851,852 | $0 | $0 | 11,493,554 (Indirect) | View |
| 2021-06-28 Purchase | 2021-06-30 9:28 pm | Bright Health Group Inc. | BHG | Behbahani Ali 10% Owner | 1,944,444 | $18 | $34,999,992 | 23,983,073 (Indirect) | View |
| 2021-06-28 Purchase | 2021-06-30 6:01 pm | Monte Rosa Therapeutics Inc. | GLUE | Behbahani Ali Director 10% Owner | 1,050,000 | $19 | $19,950,000 | 7,692,298 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-05-16 Option Award | 2023-05-17 9:16 pm | N/A 2033-05-15 | Black Diamond Therapeutics Inc. | BDTX | Behbahani Ali Director | 16,500 | $0 | 16,500 (Direct) | View |
| 2023-03-16 Option Award | 2023-03-20 4:41 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Behbahani Ali Director | 7,111 | $1.67 | 3,483,872 (Direct) | View |
| 2023-01-03 Disposition | 2023-01-04 5:16 pm | N/A 2032-06-05 | Oyster Point Pharma Inc. | OYST | Behbahani Ali Director | 24,197 | $0 | 0 (Direct) | View |
| 2022-12-20 Other | 2022-12-22 6:31 pm | N/A N/A | Arcellx Inc. | ACLX | Behbahani Ali Director | 283 | $0 | 566 (Indirect) | View |
| 2022-12-16 Option Award | 2022-12-19 9:27 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Behbahani Ali Director | 7,917 | $1.5 | 3,476,761 (Direct) | View |
| 2022-11-30 Equity Swap | 2022-12-02 5:03 pm | N/A N/A | Akouos Inc. | AKUS | Behbahani Ali 10% Owner | 4,294,207 | $0 | 0 (Indirect) | View |
| 2022-09-16 Option Award | 2022-09-19 6:39 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Behbahani Ali Director | 4,532 | $2.62 | 3,468,844 (Direct) | View |
| 2022-07-01 Option Award | 2022-07-01 5:18 pm | 2023-07-01 2032-07-01 | Adaptimmune Therapeutics PLC | ADAP | Behbahani Ali Director | 737,050 | $0 | 737,050 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-17 4:35 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Behbahani Ali Director | 5,850 | $2.03 | 3,464,312 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-16 5:29 pm | N/A 2032-06-14 | Monte Rosa Therapeutics Inc. | GLUE | Behbahani Ali Director 10% Owner | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-14 4:08 pm | N/A N/A | MINERVA SURGICAL INC | UTRS | Behbahani Ali Director | 49,792 | $2.41 | 58,279 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-13 7:08 pm | N/A 2032-06-09 | Black Diamond Therapeutics Inc. | BDTX | Behbahani Ali Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 5:46 pm | N/A 2032-06-09 | CRISPR Therapeutics AG | CRSP | Behbahani Ali Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-10 4:31 pm | N/A 2032-06-07 | Nkarta Inc. | NKTK | Behbahani Ali Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2022-06-07 Option Award | 2022-06-09 5:16 pm | N/A 2032-06-06 | CVRx Inc. | CVRX | Behbahani Ali Director | 26,985 | $0 | 26,985 (Direct) | View |
| 2022-06-06 Option Award | 2022-06-08 4:49 pm | N/A 2032-06-05 | Oyster Point Pharma Inc. | OYST | Behbahani Ali Director | 8,932 | $0 | 18,998 (Direct) | View |
| 2022-03-18 Option Award | 2022-03-18 4:15 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Behbahani Ali Director | 4,346 | $3.02 | 3,458,462 (Direct) | View |
| 2021-12-17 Option Award | 2021-12-17 4:50 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Behbahani Ali Director | 2,472 | $5.31 | 3,454,116 (Direct) | View |
| 2021-10-26 Conversion | 2021-10-28 9:06 pm | N/A N/A | MINERVA SURGICAL INC | UTRS | Behbahani Ali Director | 49,215 | $0 | 19,635 (Direct) | View |
Ownership | 2021-10-21 8:02 pm | N/A N/A | MINERVA SURGICAL INC | UTRS | Behbahani Ali Director | 0 | $0 | 5,181 (Direct) | View |
| 2021-09-17 Option Award | 2021-09-23 5:43 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Behbahani Ali Director | 1,326 | $9.9 | 3,451,644 (Direct) | View |
| 2021-07-01 Option Award | 2021-07-02 5:01 pm | 2022-07-01 2031-07-01 | Adaptimmune Therapeutics PLC | ADAP | Behbahani Ali Director | 474,385 | $0 | 474,385 (Direct) | View |
| 2021-07-01 Option Award | 2021-07-02 4:27 pm | 2022-07-01 2031-07-01 | GENOCEA BIOSCIENCES INC. | GNCA | Behbahani Ali Director 10% Owner | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-06-29 Option Award | 2021-07-01 5:35 pm | N/A 2031-06-28 | CVRx Inc. | CVRX | Behbahani Ali Director | 10,382 | $0 | 10,382 (Direct) | View |
| 2021-06-28 Conversion | 2021-06-30 9:28 pm | N/A N/A | Bright Health Group Inc. | BHG | Behbahani Ali 10% Owner | 93,285,104 | $0 | 23,983,073 (Indirect) | View |
| 2021-06-28 Conversion | 2021-06-30 6:01 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Behbahani Ali Director 10% Owner | 30,092,935 | $0 | 7,692,298 (Indirect) | View |
Ownership | 2021-06-29 9:32 pm | N/A 2023-12-14 | CVRx Inc. | CVRX | Behbahani Ali Director | 0 | $0 | 5,244 (Direct) | View |
| 2021-06-23 Option Award | 2021-06-25 5:47 pm | N/A 2031-06-22 | Monte Rosa Therapeutics Inc. | GLUE | Behbahani Ali Director 10% Owner | 47,132 | $0 | 47,132 (Direct) | View |
Ownership | 2021-06-24 9:23 pm | N/A N/A | Bright Health Group Inc. | BHG | Behbahani Ali 10% Owner | 0 | $0 | 69,963,828 (Indirect) | View |
Ownership | 2021-06-23 9:03 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Behbahani Ali Director 10% Owner | 0 | $0 | 6,642,298 (Indirect) | View |
| 2021-06-18 Option Award | 2021-06-22 7:18 pm | N/A 2031-06-17 | Black Diamond Therapeutics Inc. | BDTX | Behbahani Ali Director | 15,000 | $0 | 3,465,318 (Direct) | View |
| 2021-06-18 Option Award | 2021-06-22 7:18 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Behbahani Ali Director | 1,014 | $12.95 | 3,465,318 (Direct) | View |
| 2021-06-13 Option Award | 2021-06-15 4:25 pm | N/A 2031-06-12 | Nkarta Inc. | NKTK | Behbahani Ali Director | 16,511 | $0 | 16,511 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 6:23 pm | N/A 2031-06-10 | CRISPR Therapeutics AG | CRSP | Behbahani Ali Director | 10,000 | $0 | 10,000 (Direct) | View |